13 research outputs found

    Motion estimation for video coding: efficient algorithms and architectures

    No full text
    The need of video compression in the modern age of visual communication cannot be over-emphasized. This monograph will provide useful information to the postgraduate students and researchers who wish to work in the domain of VLSI design for video processing applications. In this book, one can find an in-depth discussion of several motion estimation algorithms and their VLSI implementation as conceived and developed by the authors. It records an account of research done involving fast three step search, successive elimination, one-bit transformation and its effective combination with diamond search and dynamic pixel truncation techniques. Two appendices provide a number of instances of proof of concept through Matlab and Verilog program segments. In this aspect, the book can be considered as first of its kind. The architectures have been developed with an eye to their applicability in everyday low-power handheld appliances including video camcorders and smartphones

    Diabetes due to recurrent pancreatitis secondary to hypercalcemia due to primary hyperparathyroidism

    No full text
    Acute pancreatitis due to hypercalcemia associated with hyperparathyroidism (HPT) is not very common. We herein report a case of a 21-year-old woman, who presented with acute pancreatitis. She had a past history of recurrent nephrolithiasis. Subsequent evaluation revealed hypercalcemia (serum calcium: 12.6 mg/dL); low phosphate (2.9 mg/dL) with elevated parathyroid hormone (PTH, 156.7 pg/mL) and HbA1c (6.9%). Diagnosis of primary HPT (PHPT) was made. Recurrent pancreatitis due to hypercalcemia may have resulted in diabetes mellitus

    Elevated carbon dioxide level along with phosphorus application and cyanobacterial inoculation enhances nitrogen fixation and uptake in cowpea crop

    No full text
    <p>Climate change, as a result of increase in the concentration of greenhouse gases, influences growth and productivity of leguminous crops. A study was carried out to analyse the impacts of elevated carbon dioxide (CO<sub>2</sub>) and cyanobacterial inoculation on growth, N<sub>2</sub> fixation and N availability and uptake in cowpea crop, under different doses of phosphorus. Cowpea crop was grown under ambient (400 µmol mol<sup>−</sup><sup>1</sup>) and elevated (550 ± 20 µmol mol<sup>−</sup><sup>1</sup>) CO<sub>2</sub> levels using Free-Air Carbon dioxide Enrichment facility. Elevated CO<sub>2</sub> level increased chlorophyll content in leaves, improved nodulation and nitrogen fixation by the crop. Increase in P dose up to 16 mg kg<sup>−</sup><sup>1</sup> soil enhanced nodule development and N<sub>2</sub> fixation under high CO<sub>2</sub> condition. Cyanobacterial inoculation increased nodule weight, leghaemoglobin content in nodules and total nitrogenase activity. Although nitrogen concentration in cowpea seeds decreased in high CO<sub>2</sub> treatment, higher N uptake was recorded. Under elevated CO<sub>2</sub> condition, cyanobacterial inoculation and higher P doses led to enhanced root growth and N<sub>2</sub> fixation and availability of soil nitrogen. The study illustrated the synergistic effect of high CO<sub>2</sub> and cyanobacterial inoculation in enhancing crop growth and availability of soil N, mediated by biological N<sub>2</sub> fixation in cowpea under different levels of P.</p

    Netarsudil monotherapy as the initial treatment for open-angle glaucoma and ocular hypertension in Indian patients: A real-world evaluation of efficacy and safety

    No full text
    Purpose: Glaucoma is the second leading cause of blindness worldwide, affecting more than 64 million people aged 40-80. The best way to manage primary open-angle glaucoma (POAG) is by lowering the intraocular pressure (IOP). Netarsudil is a Rho kinase inhibitor, the only class of antiglaucoma medications that reorganizes the extracellular matrix to improve the aqueous outflow through the trabecular pathway. Methods: An open-label, real-world, multicentric, observation-based 3-month study was performed for assessing the safety and ocular hypotensive efficacy of netarsudil ophthalmic solution (0.02% w/v) in patients with elevated IOP. Patients were given netarsudil ophthalmic solution (0.02% w/v) as a first-line therapy. Diurnal IOP measurements, best-corrected visual acuity, and adverse event assessments were recorded at each of the five visits (Day-1: screening day and first dosing day; subsequent observations were taken at 2 weeks, 4 weeks, 6 weeks, and 3 months). Results: Four hundred and sixty-nine patients from 39 centers throughout India completed the study. The mean IOP at baseline of the affected eyes was 24.84 ± 6.39 mmHg (mean ± standard deviation). After the first dose, the IOP was measured after 2, 4, and 6 weeks, with the final measurement taken at 3 months. The percentage reduction in IOP in glaucoma patients after 3 months of once-daily netarsudil 0.02% w/v solution use was 33.34%. The adverse effects experienced by patients were not severe in the majority of cases. Some adverse effects observed were redness, irritation, itching, and others, but only a small number of patients experienced severe reactions, as reported in a decreasing order: redness > irritation > watering > itching > stinging > blurring. Conclusion: We found that netarsudil 0.02% w/v solution monotherapy when used as the first-line treatment in primary open-angle glaucoma and ocular hypertension was both safe and effective
    corecore